2 completed, 1 terminated. 3 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Completed 2, Terminated 1 |
| Phase 2 | 2 | Completed 2 |
Follow NSC 366140: new trials by email Literature Review of NSC 366140 trials Research Report on NSC 366140
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Optimizing Treatment to Improve TBM Outcomes in Children High-dose: RIF, INH, PZA, EMB, High dose: RIF, INH, PZA, LEVO, Standard of care: RIF, INH, PZA, EMB - Tuberculosis, Meningeal | Phase 1 / Phase 2 | Completed | Johns Hopkins University | 38 | 2017-02-22 | 2021-10-28 |
| Pyrazoloacridine and Stem Cell or Bone Marrow Transplantation in Treating Young Patients With High-Risk Neuroblastoma pyrazoloacridine, filgrastim, autologous bone marrow transplantation - Disseminated Neuroblastoma, Recurrent Neuroblastoma | Phase 1 | Terminated | National Cancer Institute (NCI) | 42 | 2002-12-01 | 2013-04-09 |
| Pyrazoloacridine Followed by Radiation Therapy in Treating Adults With Newly Diagnosed Supratentorial Glioblastoma Multiforme pyrazoloacridine, adjuvant therapy, radiation therapy - Brain and Central Nervous System Tumors | Phase 1 / Phase 2 | Completed | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2000-05-01 | 2012-05-03 |
Central Nervous System Neoplasms (1) · Glioblastoma (1) · Gliosarcoma (1) · Neuroblastoma (1) · Tuberculosis, Meningeal (1)
Johns Hopkins University (1) · National Cancer Institute (NCI) (1) · Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins (1)
United States (2) · India (1) · Malawi (1)
Anna Butturini (1) · Glenn J. Lesser, MD (1) · Kelly Dooley, MD,PhD (1)
P01CA081403 (1), P30CA006973 (1), R01HD074944 (1), U01CA062475 (1)